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INTRODUCTION
Vitreoretinal complications including vitreous opacities, vitreoreti­
nal traction, or epiretinal membranes are common ocular findings 
during the follow­up of patients with inflammation of the posterior 
segment. Pars plana vitrectomy, traditionally performed with 20­gau­
ge instrumentation in association with pharmacotherapy has been 
a valuable tool, promoting cleansing of the vitreous opacities and 
repair of structural complications(1­3). Despite these facts, intraocular 
surgery can also exacerbate the inflammation in eyes with uveitis by 
activating the underlying inflammatory process and the procedure 
itself can cause an unusually severe inflammatory response, abnor­
mal bleeding or unexpected postoperative intraocular pressure (IOP) 
responses(4).
In 2002, Fujii et al. demonstrated the feasibility and safety of a trans ­
conjunctival sutureless 25­gauge vitrectomy system(5,6) and, since 
then, this system has been used in numerous vitreoretinal diseases. 
Among the advantages of this sutureless transconjunctival techni­
que we can consider the minimization of the surgically induced 
trau ma caused by the eye manipulation and sutures (along with the 
possible reactions related to the suture material itself ) and the shor­
tening of the time for the procedure by avoiding the opening and 
suture of sclera and conjunctiva separately, leading to a reduction in 
postoperative inflammation and quicker recovery(7­10).
This technique can be considered as ideally designed for eyes 
with uveitis, because the least traumatic surgical technique with 
minimization of postoperative inflammatory response is the key for 
the healing process in this group of patients.
The purpose of this study was to evaluate the clinical and func ­
tional results of 25­gauge pars plana vitrectomy (25 g PPV) in the 
management of patients with vitreous opacities secondary to inflam­
mation of the posterior segment of the eye.
METHODS
Twenty consecutive eyes of 19 consecutive patients with dense 
residual vitreous opacities secondary to posterior segment inflamma­
tion underwent surgical procedure between April/2007 to July/2008. 
All the patients were recruited from the Uveitis and AIDS service of 
the Universidade Federal de São Paulo ­ UNIFESP, Brazil. Informed 
consent was obtained from all patients and the study was approved 
by the Institution Ethics Committee. 
Surgeries were performed after the inflammation was controlled 
by medical treatment and all patients had quiescent uveitis for at 
least 3 months. Eyes with previous vitreoretinal surgery or retinal 
detachment were not included in this study. Diagnostic evaluation 
included a full medical history, clinical evaluation, and appropriate 
laboratory investigation.
Patients had a follow­up evaluation one week before surgery 
(ba seline) and after surgery at day 1, week 1, week 4 and week 12. 
Ophthal mic evaluation included visual acuity (VA) measured by 
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ABSTRACT
Purpose: To evaluate anatomical and functional results of 25­gauge transconjunc ­
tival sutureless pars plana vitrectomy in patients with uveitis. 
Methods: Vitrectomy was performed on 20 eyes with residual vitritis secondary to 
in fectious and noninfectious uveitis. Patients were evaluated 1 week before surgery 
and after surgery at day 1, week 1, week 4 and week 12. Visual acuity (VA), intraocular 
pressure, anterior chamber cells and flare and vitreous haze were measured. 
Results: Mean VA improved from 2.06 ± 0.94 logMAR before surgery to 0.58 ± 
0.46 logMAR at week 12 (p<0.05). No case required conversion to standard 20­gauge 
instrumentation or suture placement, no intraoperative complications were noted. 
Transient postoperative hypotony was seen in three eyes. One patient with toxoplasmic 
retinochoroiditis had a relapse during follow­up. 
Conclusion: 25­gauge vitrectomy has proven its efficacy on cleansing vitreous 
opa cities and improving visual acuity on patients with residual vitritis secondary to 
uveitis with minimal postoperative inflammation and complications.
Keywords: Vitrectomy; Uveitis; Vitreous body; Eye infections
RESUMO
Objetivo: Avaliar os resultados anatômicos e funcionais da vitrectomia via pars plana 
25-gauge transconjuntival sem sutura em pacientes com uveítes. 
Métodos: Realizou-se vitrectomia em 20 olhos com vitreíte residual secundária a uveíte 
infecciosa e não infecciosa. Os pacientes foram avaliados uma semana antes e após a 
cirurgia, no primeiro dia, 1a, 4a e 12a semana. Acuidade visual (AV), pressão intraocular, 
células e “flare” na câmara anterior e “haze” vítreo foram medidos. 
Resultados: A AV média melhorou de 2,06 ± 0,94 logMAR antes da cirurgia para 0,58 ± 
0,46 logMAR na 12a semana (p<0,05). Nenhum caso necessitou de conversão para ins-
trumentos de 20-gauge ou realização de sutura e não foram observadas complicações 
intraoperatórias. Hipotonia transitória foi observada em três olhos. Um paciente com 
retinocoroidite por toxoplasmose teve recidiva durante o acompanhamento. 
Conclusão: Vitrectomia 25-gauge provou sua eficácia na remoção do vítreo opacificado 
e na melhora da AV em pacientes com vitreíte residual secundária a uveítes, com mínima 
inflamação pós-operatória e complicações.
Descritores: Vitrectomia; Uveítes; Corpo vítreo; Infecções oculares
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Early Treatment Diabetic Retinopathy Study (ETDRS) chart, anterior 
and posterior segment slit­lamp evaluation, dilated fundus exami­
nation using binocular indirect ophthalmoscope and Goldmann 
applanation tonometry. Ocular ultrasound and Optical Coherence 
Tomography were performed when indicated. Cell and flare count 
in the anterior chamber were determined according to the SUN 
working group grading scheme(11), vitreous haze was graded based 
on standard photographs developed by Nussenblatt et al.(12) Hypo­
tony was defined as intraocular pressure (IOP) of <8 mmHg. Conver­
sion of counting fingers at two feet and hand­motion at two feet VA 
to Snellen equivalent was made according to the method proposed 
by Holladay(13) and were given values of 0.01 (+2.0 logMAR) and 0.001 
(+3.0 logMAR), respectively. 
Patients with non­infectious etiology already on systemic ste­
roids (two patients) had their prescription changed (40 mg/day on 
surge ry and tapered over the follow­up period), other three patients 
that were not under immunosuppressive treatment received an 
intraoperative subtenon triamcinolone acetonide injection (1 ml of 
a 40 mg/ml solution).
Surgical technique
The periocular skin was prepared thoroughly with 5% povido­
ne­iodine, which was followed by instillation of drops of 0,5% povi­
done­iodine into the inferior conjunctival fornix. All patients received 
peribulbar anesthesia (50:50 0,5% bupivacaine and 2% lidocaine). 
The 25 g PPV was performed using the Alcon Accurus vitrectomy 
system (Alcon Labs, Fort Worth, TX, USA) with the insertion of a can­
nula using a beveled trocar after displacement of the conjunctiva to 
misalign the conjunctival and scleral incisions. Transscleral cannulas 
were placed through the pars plana, 3.5 to 4.0 mm from the limbus, 
in the su peronasal, superotemporal, and inferotemporal quadrants. 
The inferotemporal cannula was the site of infusion, and both supe­
rior quadrant cannulas were used for intraocular instrumentation. All 
eyes underwent total vitrectomy followed by elevation and removal 
of the posterior hyaloid membrane and fluid/gas exchange. Other 
procedures like epiretinal membrane peeling and endolaser photo­
coagulation were performed as needed during vitreous surgery. The 
peripheral retina was inspected using the wide­field contact lens 
(same used for the surgical procedure) and scleral depression with 
the trocars still in place. At the end of surgery, the infusion line was 
clamped, and the superonasal and superotemporal canullas were re­
moved. The sclerotomy site was inspected for fluid or air leakage, and 
then the infusion cannula was removed. Total time for the procedure 
(from insertion of the trocars to removal of the cannulas) was recor­
ded. For eyes with lens opacification, cataract phacoemulsification 
was combined with vitrectomy.
Postoperatively, topical 0.3% ciprofloxacin or 0.5% moxifloxacin 
were administered four times daily for 10 days and 1% topical pred­
nisolone acetate, 6 times a day with slow tapering over the follow­up 
period according to the postoperative recovery. Patients in use of 
systemic anti­inflammatory agents maintained the therapy during 
the follow­up.
StatiStical analySiS
Statistical analysis was performed using SigmaStat 3.11 (SPSS Inc, 
Chicago, IL). The distribution of continuous variable is expressed 
as mean ± standard deviation and categorical data are presented 
as frequencies. Changes in VA and IOP over time were analyzed by 
Friedman’s repeated measures analysis of variance on ranks, with 
statistical significance set at two­sided p<0.05.
RESULTS
The mean age of the 12 women and 7 men was 41.79 ± 14.63 
years (range 16 to 65 years). The etiology was diagnosed as infectious 
in 13 eyes (65%), non infectious in 4 eyes (20%) and idiopathic in 3 
eyes (15%) (Table 1). One patient with posterior uveitis secondary 
to tuberculosis had bilateral disease and underwent surgery in both 
eyes. Eighteen eyes were phakic and two aphakic before surgery. 
Mean operative time was 31.15 ± 14.55 minutes (Median 27.50 mi­
nutes). Combined cataract phacoemulsification with IOL implanta­
tion was performed in three patients. Two patients who developed 
cataract during the follow­up also underwent phacoemulsification 
with IOL implantation before the final visit. No case required conver­
sion to standard 20­gauge instrumentation or suture placement in 
the sclerotomies and no major intra or postoperative complications 
were noted.
Improvement in visual acuity was achieved in all patients of our 
series, mean VA improved from 2.06 ± 0.94 logMAR before surgery to 
1.91 ± 0.93, 1.16 ± 0.94, 0.71 ± 0.56 and 0.58 ± 0.46 logMAR, respecti­
vely at day 1, week 1, week 4 and week 12 (Figure 1). 
Anterior chamber cell activity of 1+ or greater was observed in 6 
eyes (30%) before surgery, in 13 eyes (65%) at day 1, in 12 eyes (60%) 
at week 1 and in 2 (10%) eyes on the at week 4, only one eye (5%) had 
more than 1+ anterior chamber cell activity 12 weeks after surgery 
(Table 2). Anterior chamber flare assessments are presented in table 2.
All patients had vitreous haze of 2+ or greater before surgery, 
after surgery all patients has less than 2+ vitreous haze (Table 2).
 Mean IOP before the procedure was 13.9 ± 2.8 mmHg and mean 
IOP on day 1, week 1, week 4 and week 12 were 11.7 ± 4.3 mmHg, 
14.5 ± 8.4 mmHg, 14.2 ± 5.7 mmHg and 14.5 ± 5.1 mmHg, respecti­
vely (Table 2). 
Table 1. Etiology of uveitis
Etiology
Number of eyes 
n (%)
Toxoplasmic retinochoroiditis 11 (55.0)
Tuberculous uveitis 02 (10.0)
Behçet’s disease 01 (05.0)
Vogt­Koyanagi­Harada disease 01 (05.0)
Sarcoidosis 01 (05.0)
Sympathetic ophthalmia 01 (05.0)
Pars planitis 01 (05.0)
Idiopathic diffuse uveitis 02 (10.0)
Figure 1. Mean change from baseline over time in visual acuity. Vertical bars are ± 1 
standard deviations from the mean.
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No case of infective endophthalmitis occurred. Postoperative hy ­
potony was seen in three eyes and was associated with peripheral 
choroidal detachment in two eyes. Secondary cataract progression 
occurred in three eyes in our series (20.0% of the phakic eyes) during 
the follow­up period and phacoemulsification with intraocular lens 
implantation was performed in two of them before the final visit. One 
eye that underwent subtenon injection of triamcinolone acetonide 
experienced an IOP elevation with poor response to appropriate cli­
nical therapy and was further referred to glaucoma filtering surgery. 
One patient with toxoplasmic retinochoroiditis had a relapse during 
the second month of follow­up and was successfully treated with tri­
methoprim/sulfamethoxazole associated with systemic prednisone. 
His visual acuity at the last visit (week 12) was 0.50 logMAR.
DISCUSSION
Intraocular surgery has been reported to induce exacerbations in 
different types of uveitis(1­4,14­20). In cataract surgery, the surgical mana­
gement with small incisions allowed minimization of surgical trauma 
and inflammatory response lowering the rate of complications with 
better visual prognosis for the patients(3,4). In posterior segment sur­
gery, the new transconjunctival sutureless vitrectomy systems have 
the same premises, minimizing surgical manipulation and hastening 
of postoperative recovery, resulting in a decreased postoperative 
intraocular inflammatory response(5,6).
The use of more flexible and smaller­gauge vitrectomy probes 
have some limitations, like lesser ability to move the eye, reduced 
cu tting and aspirating speed(15,20). A careful selection of patients is 
crucial and vitreoretinal conditions requiring minimal intraocular 
ma nipulation and tissue dissection are usually better indicated 
for this type of procedure(15). None of our patients required suture 
placement or conversion to 20­gauge technique; this fact is related 
to the meticulous indication of surgeries. As many of these patients 
had media haziness with impaired visualization of the fundus, ocular 
ultrasonography was a valuable tool in the preoperative evaluation 
of these patients.
None of our patients developed fibrin formation or new posterior 
synechia; this fact can be related to the adequate preoperative and 
postoperative control of inflammation. Postoperative hypotony and 
cataract progression were the most frequent complications seen 
and both occurred in three eyes. Postoperative hypotony is a known 
complication of sutureless surgical procedures and is most likely to 
occur in the first postoperative day(5­10). In two of our patients it was 
associated with peripheral choroidal detachment, but they resolved 
spontaneously during the first week and did not require further sur­
gical procedure. Cataract formation is also a common complication 
following pars plana vitrectomy and uveitis and occurred in 20.0% of 
our phakic patients in a three month follow­up period. Two patients 
with significant lens opacities successfully undergone phacoemul­
sification with IOL implantation. Worsening of cataract is expected 
in more patients of our series in a longer follow­up as shown on a 
previous study(10). One eye presented on week 1 an IOP of 30 mmHg 
and maintained ocular hypertension despite adequate clinical ma­
nagement, being further referred to glaucoma filtering surgery; this 
eye underwent an intraoperative subtenon triamcinolone acetonide 
injection and this procedure could be the cause of these finding. 
Uveitis relapse was seen in only one eye in our series, this patient 
had toxoplasmic retinochoroiditis and developed a re­activation in 
the second month of follow­up; an increased risk of reactivation of 
ocular toxoplasmosis following cataract surgery was described by 
Bosch­Driessen et al.,(17) reactivation occurred in 5/15 eyes within four 
months of cataract surgery (three within three months), a higher rate 
than we have found.
Sutureless ophthalmic surgery has been associated with an in ­
creased risk of endophthalmitis(18­20), this is also a concern in 25 g 
PPV and a prospective study will be needed to settle this issue. Our 
patients were carefully prepared with povidone­iodine, the lashes 
were draped during surgery, prophylactic antibiotic was used in the 
postoperative period and no cases of endophthalmitis were seen.
In patients with residual vitritis due to posterior segment infla­
mation, 25 g PPV showed to be a feasible and safe technique, with 
low postoperative inflammatory response and relapse rate. Vitreous 
clearance and visual acuity improvement was achieved in all patients 
without any major intraoperative or postoperative complication. As 
a diagnostic procedure 25 g PPV can play an important role once it 
produced only minimal surgical trauma and inflammatory response. 
Besides that, the technique shows advantages as the preservation 
of an intact conjunctiva in patients who are at risk of needing glau­
coma filtration surgery or who already have filtering blebs(21). An 
improvement in the course of uveitis after pars plana vitrectomy was 
described previously(1­3), in our study the follow­up period was too 
short to perform such type of evaluation, although, anterior chamber 
cells activity and flare decreased from the preoperative to the final 
visit and this could be an indicator of better control of inflammation. 
CONCLUSION 
Twenty­five gauge vitrectomy has proven its efficacy on clean­
sing vitreous opacities and improving visual acuity on patients with 
residual vitritis secondary to uveitis with minimal postoperative in ­
flammation and complications related to the procedure.
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